Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · BILL · 118th Congress · S. 2333 (Introduced in Senate) — To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-ha... · Sec. 207

Sec. 207. Medical countermeasures for viral threats with pandemic potential

259 words·~1 min read·/bill/118/s/2333/is/section-207·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 319L of the Public Health Service Act ( 42 U.S.C. 247d–7e ) is amended— in subsection (c)(4)— in subparagraph (D), by amending clause
(iii)to read as follows: conduct research to promote strategic initiatives, such as— rapid diagnostics; broad spectrum antimicrobials; medical countermeasures for virus families that have significant potential to cause a pandemic, including such countermeasures that take either pathogen-specific or broad spectrum approaches; and technologies to improve the production and use of medical countermeasures, which may include vaccine-manufacturing technologies, dose-sparing technologies, efficacy-increasing technologies, platform technologies, technologies to administer countermeasures, and technologies to improve storage and transportation of countermeasures. ; and in subparagraph (F), by amending clause
(ii)to read as follows: threats that— consistently exist or continually circulate and have a significant potential to become a pandemic, such as pandemic influenza; or include priority virus families and other viral pathogens with a significant potential to cause a pandemic; and may include the advanced research and development, manufacturing, and appropriate stockpiling of qualified pandemic or epidemic products, and products, technologies, or processes to support the advanced research and development of such countermeasures (including multiuse platform technologies for diagnostics, vaccines, and therapeutics; virus seeds; clinical trial lots; novel virus strains; and antigen and adjuvant material); ; in subsection (d)(2), by striking $611,700,000 for each of fiscal years 2019 through 2023 and inserting $950,000,000 for each of fiscal years 2024 through 2028 ; and in subsection (e)(1), by amending subparagraph
(D)to read as follows: This paragraph shall cease to have force or effect after September 30, 2028. .
Connections1 off-index
1 reference not yet in our index
  • 42 USC 247d–7e
Citation graph
cites case law
Sec. 207
Medical countermeasures for viral threats with pandemic potential
Cite42 USC 247d–7e
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.